Michele C. Bosch

Specialty / focus areas. Michele C. Bosch is a registered patent attorney and IP partner in Finnegan, Henderson, Farabow, Garrett & Dunner's Washington, DC office, where she has spent her entire career. Her practice centers on patent portfolio development, management, and analysis, prosecution, due diligence, and validity/infringement opinions, with particular strength in post-grant proceedings (IPR, PGR) and patent interferences. She works predominantly in chemistry and life sciences — pharmaceuticals, biotechnology, consumer products, cosmetics, nutraceuticals, agrichemicals, polymers, petrochemicals, minerals, and metals — reflecting her undergraduate chemistry background. She has led Finnegan's chemical/metallurgy and life sciences practice groups and served on the firm's management and compensation committees.

Side preference and firm context. Her tracked litigation appearance is plaintiff-side, representing operating company Microsoft against InterDigital Patent Holdings in a standard-essential patent licensing/FRAND dispute — squarely on the side of a practicing operating company rather than an NPE/PAE. Her PTAB practice is two-sided: she both challenges competitor patents and defends high-value commercial portfolios as lead counsel. All web-searchable matter history is through Finnegan; no prior firms are documented.

Notable cases and PTAB/IPR experience. The tracked matter, Microsoft Corp. et al. v. InterDigital Patent Holdings Inc., involved 3G/4G standard-essential patent licensing conduct. Other documented matters include Corbion NV v. WTI, Inc. (S.D. Ga., dry vinegar products) and a successful interference win for PQ Corp. against Johnson Matthey concerning chabazite-type zeolites (BPAI). She appears regularly before the PTAB as lead or backup counsel — e.g., as lead petitioner's counsel in a 2023 IPR filing and for clients including Sequenom and 3M — and Legal 500 has specifically recognized her post-grant and interference work.

Bar / education. UVA B.A. in Chemistry (biochemistry), 1990; William & Mary Law School J.D., 1993. Admitted in Virginia, DC, the USPTO, and the Federal Circuit; a Best Lawyers honoree for patent litigation since 2023 and an LMG Life Sciences Star.